Analysis of the transforming growth factor-β1 gene promoter polymorphisms in early osseointegrated implant failure

Implant Dentistry

Volumn 13, Issue 3, 2004, Pages 262-269

  Dos Santos, Maria Cristina Leme Godoy ^a   Campos, Maria Isabela Guimarães ^a   Souza, Ana Paula ^b   Scarei Caminaga, Raquel Mantuaneli ^b   Mazzonetto, Renato ^a   Line, Sergio Roberto Peres ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSIDADE DO SAGRADO CORAÇÃO   (Brazil)

Author keywords

Early failure; Osseointegration; Polymorphism; TGF 1

Indexed keywords

CYTOKINE; TRANSFORMING GROWTH FACTOR BETA1; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; BONE REGENERATION; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; GENE AMPLIFICATION; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENOMICS; GENOTYPE; HAPLOTYPE; HUMAN; MALE; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROSTHESIS FAILURE; SINGLE NUCLEOTIDE POLYMORPHISM; TOOTH PROSTHESIS; WOUND HEALING; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; DENTAL SURGERY; GENE FREQUENCY; GENETICS; MIDDLE AGED; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TOOTH IMPLANTATION;

CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DENTAL IMPLANTS; DENTAL RESTORATION FAILURE; FEMALE; GENE FREQUENCY; HUMANS; MALE; MIDDLE AGED; OSSEOINTEGRATION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 7944223871     PISSN: 10566163     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.id.0000140463.10204.87     Document Type: Article

References (62)

1. Massagué J. The transforming growth factor-β family. Annu Rev Cell Biol. 1990;6:597-641.
2. Syrris P, Carter ND, Metcalfe JC, et al. Transforming growth factor-beta1 gene polymorphisms and coronary artery disease. Clin Sci (Lond). 1998;95:659-667.
3. Derynck R, Jarrett JA, Chen EY, et al. Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells. Nature. 1985;316:701-705.
4. Pulleyn LJ, Newton R, Adcock IM, et al. TGFbeta1 allele association with asthma severity. Hum Genet. 2001;109:623-627.
5. Lácha J, Hubacek JA, Potmesil P, et al. TGF-beta I gene polymorphism in heart transplant recipients-effect on renal function. Ann Transplant. 2001;6:39-43.
6. Wang D, Kanuma T, Mizunuma H, et al. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer. Cancer Res. 2000;60:4507-4512.
7. Polyak K. Negative regulation of cell growth by TGF-beta1. Biochim Biophys Acta. 1996;1242:185-199.
8. de Martin R, Haendler B, HoferWarbinek R, et al. Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-beta gene family. EMBO J. 1987;6:3673-3677.
9. Wrann M, Bodmer S, de Martin R, et al. T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor-beta. EMBO J. 1987;6:1633-1636.
10. Ignotz RA, Massague J. Cell adhesion protein receptors as targets for transforming growth factor-beta action. Cell. 1987;51:189-197.
11. Mustoe TA, Pierce GF, Thomason A, et al. Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta. Science. 1987;237:1333-1336.
12. Fujii D, Brissenden JE, Derynck R, et al. Transforming growth factor beta gene maps to human chromosome 19 long arm and to mouse chromosome 7. Somat Cell Mol Genet. 1986;12:281-288.
13. Cambien F, Ricard S, Troesch A, et al. Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. Hypertension. 1996;28:881-887.
14. th ed. Philadelphia: Thompson & Thompson; 1991.
15. Hobbs K, Negri J, Klinnert M, et al. Interleukin-10 and transforming growth factor-beta promoter polymorphisms in allergies and asthma. Am J Respir Crit Care Med. 1998;158:1958-1962.
16. Grainger DJ, Metcalfe JC. Transforming growth factor-beta and cardiovascular protection. In: Rubanyi GM, Dzau, VJ, eds. The Endothelium in Clinical Practice. Source and Target of Novel Therapies. 1st ed. New York: Marcel Dekker Inc.; 1997:203-243.
17. Grainger DJ, Heathcote K, Chiano M, et al. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet. 1999;8:93-97.
18. Colletta AA, Wakefield LM, Howell FV, et al. The growth inhibition of human breast cancer cells by a novel synthetic progestin involves the induction of transforming growth factor beta. J Clin Invest. 1991;87:277-283.
19. Harrison NK, Argent AC, McAnulty RJ, et al. Collagen synthesis and degradation by systemic sclerosis lung fibroblasts. Responses to transforming growth factor-beta. Chest. 1991;99:71S-72S.
20. Broekelmann TJ, Limper AH, Colby TV, et al. Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci USA. 1999;88:6642-6646.
21. Finkelman RD, Bell NH, Strong DD, et al. Ovariectomy selectively reduces the concentration of transforming growth factor beta in rat bone: implications for estrogen deficiency-associated bone loss. Proc Natl Acad Sci USA. 1992;89:12190-12193.
22. Grainger DJ, Kemp PR, Liu AC, et al. Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice. Nature, 1994;370:460-462.
23. Souza AP, Trevilatto PC, Scarel-Caminaga RM, et al. Analysis of TGF-beta1 promoter polymorphism (C-509T) in patients with chronic periodontitis. J Clin Periodontol. 2003;30:519-523.
24. Trevilatto PC, Line SR. Use of buccal epithelial cells for PCR amplification of large DNA fragments. J Forensic Odontostomatol. 2000;18:6-9.
25. Sanguinetti CJ, Dias Neto E, et al. Rapid silver staining and recovery of PCR products separated on polyacrylamide gels. Biotechniques. 1994;17:914-921.
26. Sham PC, Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet. 1995;59:97-105.
27. Esposito M, Hirsch JM, Lekholm U, et al. Biological factors contributing to failures of osseointegrated oral implants. (I). Success criteria and epidemiology. Eur J Oral Sci. 1998;106:527-551.
28. Santos MCLG, Campos MIG, Line SRP. Early dental implant failure: a review of the literature. Braz J Oral Sci. 2002;1:103-111.
29. Adell R, Lekholm U, Rockler B, et al. Marginal tissue reactions at osseointegrated titanium fixtures (I). A 3-year longitudinal prospective study. Int J Oral Maxillofac Surg. 1986;15:39-52.
30. Lekholm U, Adell R, Lindhe J, et al. Marginal tissue reactions at osseointegrated titanium fixtures. (II) A cross-sectional retrospective study. Int J Oral Maxillofac Surg. 1986;15:53-61.
31. Seymour GJ, Gemmell E, Lenz LJ, et al. Immunohistologic analysis of the inflammatory infiltrates associated with osseointegrated implants. Int J Oral Maxillofac Implants. 1989;4:191-198.
32. Salvi GE, Brown CE, Fujihashi K, et al. Inflammatory mediators of the terminal dentition in adult and early onset periodontitis. J Periodontal Res. 1998;33:212-225.
33. Dongari-Bagtzoglou AI, Ebersole JL. Increased presence of interleukin-6 (IL-6) and IL-8 secreting fibroblast subpopulations in adult periodontitis. J Periodontol. 1998;69:899-910.
34. Heath JK, Atkinson SJ, Hembry RM, et al. Bacterial antigens induce collagenase and prostaglandin E2 synthesis in human gingival fibroblasts through a primary effect on circulating mononuclear cells. Infect Immun. 1987;55:2148-2154.
35. Kao RT, Curtis DA, Richards DW, et al. Increased interleukin-1beta in the crevicular fluid of diseased implants. 1997. Int J Oral Maxillofac Implants. 1997;10:696-701.
36. Salcetti JM, Moriarty JD, Cooper LF, et al. The clinical, microbial, and host response characteristics of the failing implant. Int J Oral Maxillofac Implants. 1997;12:32-42.
37. Adamo CT, Mailhot JM, Smith AK, et al. Connexin-43 expression in oral-derived human osteoblasts after transforming growth factor-beta and prostaglandin E2 exposure. J Oral Implantol. 2001;27:25-31.
38. Panagakos FS, Aboyoussef H, Dondero R, et al. Detection and measurement of inflammatory cytokines in implant crevicular fluid: a pilot study. Int J Oral Maxillofac Implants. 1996;11:794-799.
39. Aboyoussef H, Carter C, Jandinski JJ, et al. Detection of prostaglandin E2 and matrix metalloproteinases in implant crevicular fluid. Int J Oral Maxillofac Implants. 1998;13:689-696.
40. Greensteing G, Hart TC. A critical assessment of interleukin-1 (IL-1) genotype when used in a genetic susceptibility test for severe choronic periodontitis. J Periodontol. 2002;73:231-247.
41. Holla LI, Fassmann A, Benes P, et al. 5 polymorphisms in the transforming growth factor-beta 1 gene (TGF-beta 1) in adult periodontitis. J Clin Periodontol. 2002;29:336-341.
42. Luedecking EK, DeKosky ST, Mehdi H, et al. Analysis of genetic polymorphisms in the transforming growth factor-beta 1 gene and the risk of Alzheimer's disease. Hum Genet. 2000;106:565-569.
43. Yokota M, Ichihara S, Lin TL, et al. Association of a T29→C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation. 2000;101:2783-2787.
44. Arkwright PD, Laurie S, Super M, et al. TGF-beta(1) genotype and accelerated decline in lung function of patients with cystic fibrosis. Thorax. 2000;55:459-462.
45. Pulleyn LJ, Newton R, Adcock IM, et al. TGF-beta1 allele association with asthma severity. Hum Genet. 2001;109:623-627.
46. Mc Donnell GV, Kirk CW, Hawkins SA. Lack of association of transforming growth factor (TGF)-beta 1 and beta 2 gene polymorphisms with multiple sclerosis (MS) in Northern Ireland. Mult Scler. 1999;5:105-109.
47. Frossard PM, Pravica V, Perrey C, et al. Lack of association between human TGF-beta1 gene variants and primary hypertension. Am J Hypertens. 2000;13:944-945.
48. Buckova D, Izakovicova Holla L, Benes P, et al. TGF-beta1 gene polymorphisms. Allergy. 2001;56:1236-1237.
49. Bijlsma FJ, van der Horst AA, Tilanus MG, et al. No association between transforming growth factor beta gene polymorphism and acute allograft rejection after cardiac transplantation. Transpl Immunol. 2002;10:43-47.
50. Alansari A, Hajeer A, Teh LS, et al. Transforming growth factor-12 polymorphism and systemic lupus erythematosus. J Rheumatol. 2002;29:1189-1191.
51. Gewaltig J, Mangasser-Stephan K, Gartung C, et al. Association of polymorphisms of the transforming growth factor-betal gene with the rate of progression of HCV-induced liverfibrosis. Clin Chim Acta. 2002;316:83-94.
52. Wilson TG Jr, Nunn M. The relationship between the interleukin-1 periodontal genotype and implant loss. Initial data. J Periodontol. 1999;70:724-729.
53. Greensteing G, Hart TC. A critical assessment of interleukin-1 (IL-1) genotype when used in a genetic susceptibility test for severe choronic periodontitis. J Periodontol. 2002;73:231-247.
54. Rogers MA, Figliomeni L, Baluchova K, et al. Do interleukin-1 polymorphisms predict the development of periodontitis or the success of dental implants? J Periodont Res. 2002;37:37-41.
55. Feloutzis A, Lang NP, Tonetti MS, et al. IL-1 gene polymorphism and smoking as risk factors for peri-implant bone loss in a well-maintained population. Clin Oral Implant Res. 2003;14:10-17.
56. Santos MCLG, Campos MIG, Souza AP, et al. Analysis of MMP-1 and MMP-9 promoter polymorphisms in early osseointegrated implant failure. Int J Oral Maxillofac Implants. 2004;19:38-43.
57. Souza AP, Trevilatto PC, Scarel-Caminaga RM, et al. MMP-1 promoter polymorphism: association with chronic periodontitis severity in a Brazilian population. J Clin Periodontol. 2003;30:154-158.
58. Musso T, Espinoza-Delgado I, Pulkki K, et al. Transforming growth factor beta downregulates interleukin-1 (IL-1)-induced IL-6 production by human monocytes. Blood. 1990;76:2466-2469.
59. Steinsvoll S, Halstensen TS, Schenck K. Extensive expression of TGF-beta1 in chronically-inflamed periodontal tissue. J Clin Periodontol. 1999;26:366-373.
60. Page RC. Host response tests for diagnosing periodontal diseases. J Periodontol. 1992;63:356-366.
61. Birkedal-Hansen H. Role of matrix metalloproteinases in human periodontal diseases. J Periodontol. 1993;64:4744-4784.
62. Stanczuk GA, Tswana SA, Bergstrom S. et al. Polymorphism in codons 10 and 25 of the transforming growth factorbeta 1 gene in patients with invasive squamous cell carcinoma of the uterine cervix. Eur J Immunogenet. 2002;29:417-421.